Hu Yuelin, Huang Jialing, Wang Shuqing, Sun Xin, Wang Xin, Yu Hongsong
Department of Immunology, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, Guizhou, P.R. China.
School of Basic Medical Sciences, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi, Guizhou, P.R. China.
Inflammation. 2025 Apr;48(2):676-695. doi: 10.1007/s10753-024-02079-2. Epub 2024 Jun 25.
Autoimmune diseases (AIDs) are immune system disorders where the body exhibits an immune response to its own antigens, causing damage to its own tissues and organs. The pathogenesis of AIDs is incompletely understood. However, recent advances in immune repertoire sequencing (IR-seq) technology have opened-up a new avenue to study the IR. These studies have revealed the prevalence in IR alterations, potentially inducing AIDs by disrupting immune tolerance and thereby contributing to our comprehension of AIDs. IR-seq harbors significant potential for the clinical diagnosis, personalized treatment, and prognosis of AIDs. This article reviews the application and progress of IR-seq in diseases, such as multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and type 1 diabetes, to enhance our understanding of the pathogenesis of AIDs and offer valuable references for the diagnosis and treatment of AIDs.
自身免疫性疾病(AIDs)是免疫系统紊乱疾病,机体对自身抗原产生免疫反应,导致自身组织和器官受损。AIDs的发病机制尚未完全明确。然而,免疫组库测序(IR-seq)技术的最新进展为研究免疫组库开辟了一条新途径。这些研究揭示了免疫组库改变的普遍性,可能通过破坏免疫耐受诱导AIDs,从而有助于我们对AIDs的理解。IR-seq在AIDs的临床诊断、个性化治疗和预后方面具有巨大潜力。本文综述了IR-seq在多发性硬化症、系统性红斑狼疮、类风湿性关节炎和1型糖尿病等疾病中的应用和进展,以加深我们对AIDs发病机制的理解,并为AIDs的诊断和治疗提供有价值的参考。